Systemic infusion of autologous adipose tissue-derived mesenchymal stem cells in peritoneal dialysis patients: feasibility and safety

Sudabeh, Alatab; Soroosh, Shekarchian; Iraj, Najafi; Reza, Moghadasali; Naser, Ahmadbeigi; Mohammad, Pourmand; Tina, Bolurieh; Neda, Jaroughi; Gholamreza, Pourmand; Nasser, Aghdami

Sudabeh, Alatab; Soroosh, Shekarchian; Iraj, Najafi; Reza, Moghadasali; Naser, Ahmadbeigi; Mohammad, Pourmand; Tina, Bolurieh; Neda, Jaroughi; Gholamreza, Pourmand; Nasser, Aghdami.

Cell Journal [Yakhteh]. 2019; 20 (4): 483-495

en Inglés | IMEMR | ID: emr-199617

ABSTRACT

ABSTRACT

Objective:

Using mesenchymal stem cells [MSCs] is regarded as a new therapeutic approach for improving fibrotic diseases.The aim of this study to evaluate the feasibility and safety of systemic infusion of autologous adipose tissue-derived MSCs [AD-MSCs] in peritoneal dialysis [PD] patients with expected peritoneal fibrosis

Buscar en Google

Imprimir

XML

Índice: IMEMR (Mediterraneo Oriental) Tipo de estudio: Ensayo Clínico Controlado Idioma: Inglés Revista: Cell J. [Yakhteh] Año: 2019

Similares

MEDLINE

LILACS

LIS

Buscar en Google

Imprimir

XML

Índice: IMEMR (Mediterraneo Oriental) Tipo de estudio: Ensayo Clínico Controlado Idioma: Inglés Revista: Cell J. [Yakhteh] Año: 2019